atorvastatin has been researched along with Age-Related Macular Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Giansanti, F; Guzman-Aranguez, A; Kaur, IP; Papucci, L; Perez de Lara, MJ; Schiavone, N; Singh, M; Yadav, M | 1 |
| Al-Moujahed, A; Bouzika, P; Hu, Y; Lin, H; Miller, JW; Notomi, S; Tian, B; Tsoka, P; Vavvas, DG | 1 |
| Daniels, AB; Eliott, D; Ganotakis, E; Goldfarb, JW; Gragoudas, ES; Kapsala, ZG; Kim, IK; Loewenstein, JI; Miller, JW; Tsilimbaris, MK; Vavvas, DG; Young, LH | 1 |
3 other study(ies) available for atorvastatin and Age-Related Macular Degeneration
| Article | Year |
|---|---|
Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).
Topics: Animals; Apoptosis; Atorvastatin; Cell Proliferation; Cells, Cultured; Cornea; Drug Liberation; Epithelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Macular Degeneration; Male; Nanoparticles; Ophthalmic Solutions; Permeability; Rabbits; Rats; Swine | 2020 |
Atorvastatin Promotes Phagocytosis and Attenuates Pro-Inflammatory Response in Human Retinal Pigment Epithelial Cells.
Topics: Atorvastatin; Cell Line; Cholesterol; Epithelial Cells; Humans; Inflammation; Interleukin-6; Interleukin-8; Lipoproteins, LDL; Macular Degeneration; Phagocytosis; Retinal Pigment Epithelium | 2017 |
Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment.
Topics: Aged; Atherosclerosis; Atorvastatin; Female; Humans; Macular Degeneration; Male; Middle Aged; Pregnancy; Prospective Studies; Retinal Detachment; Retinal Drusen; Retinal Pigment Epithelium; Risk Factors; Tomography, Optical Coherence; Visual Acuity | 2016 |